REGISTERED NUMBER: 16059683 (England and Wales)

Unaudited Financial Statements

for the Period 4 November 2024 to 30 November 2025

for

Sapre Medicolegal Ltd

Page

Balance Sheet

1

FIXED ASSETS

893

CURRENT ASSETS

18,170

CREDITORS

Amounts falling due within one year

(9,454

)

NET CURRENT ASSETS

8,716

TOTAL ASSETS LESS CURRENT LIABILITIES

9,609

CAPITAL AND RESERVES

9,609

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Sapre Medicolegal Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

16059683

Registered office:

6 Margaret Road

Crosby

Liverpool

L23 6TR

The presentation currency of the financial statements is the Pound Sterling (£).

2.	PERIOD OF ACCOUNTS

Sapre Medicolegal Limited was incorporated on 4 November 2024 and commenced trading thereafter. The company's accounting reference period ends on 30 November 2025 and these accounts cover the period from 4 November 2024 to 30 November 2025.

3.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was NIL.

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 23 July 2026 and were signed on its behalf by:

Professor B Sapre - Director